Teva Pharmaceutical
TEVA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 3 days ago • TEVA
Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar CandidateGlobeNewsWire • 6 days ago • TEVA
Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024Business Wire • 13 days ago • TEVA
Medincell's Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris®Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.